Costs Are “Valid” Selection Factor In Medicare “Coverage With Evidence Development” Option – NIH Bioethicists
This article was originally published in The Pink Sheet Daily
Executive Summary
Medicare CED policy does not compromise ethical standards for medical research, they conclude in JAMA commentary.